{"id":"W255353348","doi":"10.1016/j.taap.2015.05.004","title":"Osilodrostat (LCI699), a potent 11β-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats","year":2015,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada; Novartis Pharmaceuticals Corporation","keywords":"Pasireotide; Medicine; Somatostatin; Internal medicine; Endocrinology; Adverse effect; Combination therapy; Acromegaly; Pharmacology; Hormone","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007717186,0.002014638,0.001794236,0.00120341,0.000616047,0.0004225093,0.001002092,0.001092479,0.001760065],"category_scores_gemma":[0.0002201924,0.0009946299,0.001624294,0.0005094119,0.001345177,0.001287853,0.0004398434,0.003208347,0.0006337545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006652888,"about_ca_system_score_gemma":0.0009349746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001883489,"about_ca_topic_score_gemma":0.003807499,"domain_scores_codex":[0.9995093,0.00008077715,0.00003476346,0.00011437,0.00008846213,0.0001723022],"domain_scores_gemma":[0.9991835,0.00007238132,0.0002063923,0.00009740696,0.00008363415,0.0003567037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04181509,0.04616875,0.001905336,0.0003736508,0.0003038412,0.0003549258,0.0002215967,0.0007022758,0.8888311,0.0001576758,0.0003347968,0.018831],"study_design_scores_gemma":[0.004237385,0.4724919,0.01337095,0.00003026489,0.0006622167,0.0004492408,0.0003176089,0.001163878,0.5042449,0.0001571525,0.002785561,0.0000890093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970418,0.001125296,0.0007489296,0.00009426224,0.00006274059,0.0001511321,0.0003265116,0.00005530384,0.000394065],"genre_scores_gemma":[0.9850752,0.003879025,0.00190235,0.0001520775,0.000111528,0.0004215095,0.00098846,0.00004498756,0.007424856],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002014638,"threshold_uncertainty_score":0.005887985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02825811622487261,"score_gpt":0.3018276561857572,"score_spread":0.2735695399608846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}